DaVita®, the kidney care division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading provider of kidney care services, today announced the formation of a joint venture with Riches Healthcare (RHC), through which a new entity - DaVita Taiwan - will provide services to four dialysis clinics. DaVita will own a majority share of the joint venture entity.
"Expanding our presence into Taiwan is a key step in our long-term growth strategy in Asia," said Dennis Kogod, chief operating officer at DaVita.
The four clinics currently serviced by RHC are located in and around Taipei, have a combined number of 88 stations and are providing hemodialysis treatments to more than 250 patients.
"This acquisition is an exciting opportunity not only to expand into Taiwan, but also to do so with a well-respected and highly experienced team," said Atul Mathur, president of Asia Pacific at DaVita. "With the addition of this JV, DaVita is now serving patients in five countries across the Asia Pacific region."
As a leading provider of kidney care services in the United States, DaVita has achieved clinical outcomes that have improved year-over-year for more than a decade and plans to bring that track record of sustained clinical excellence to Taiwan.